Related references
Note: Only part of the references are listed.Antimicrobial activities of ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Molecular epidemiology of clinically significant antibiotic resistance genes
P. M. Hawkey
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Interactions of ceftobiprole with β-lactamases from molecular classes A to D
Anne Marie Queenan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis, model
Cedric Jacqueline et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes
Shazad Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase
M. Shahid et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel
Kimberley Clawson Stone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Klebsiella pneumomae isolate producing at least eight different β-lactamases, including AmpC and KPC β-lactamases
Ellen Smith Moland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animals
Takahiro Shibayama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Activities of ceftobiprole and other β-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x
TA Davies et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
ISCR elements: Novel gene-capturing systems of the 21st century?
MA Toleman et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2006)
The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
David M. Livermore et al.
TRENDS IN MICROBIOLOGY (2006)
Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea
K Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin
T Bogdanovich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains
HS Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem
T Koga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium
S Bratu et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Metallo-β-lactamases:: the quiet before the storm?
TR Walsh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
First isolation of blaVIM-2 in Latin America:: Report from the SENTRY Antimicrobial Surveillance Program
RE Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Spread of blaVIM-1-producing E-coli in a university hospital in Greece.: Genetic analysis of the integron carrying the blaVIM-1 metallo-β-lactamase gene
EV Scoulica et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
In vitro activity of AVE1330A, an innovative broad-spectrum non-β-lactam β-lactamase inhibitor
A Bonnefoy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
CS-023 (R-115685), a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa
KS Thomson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci
M Kurazono et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City
PA Bradford et al.
CLINICAL INFECTIOUS DISEASES (2004)
Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase
M Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
bla(VIM-7), an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States
MA Toleman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d′ β-lactamase in Pseudomonas aeruginosa
MA Toleman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Properties and potential of ertapenem
DM Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria
P Butaye et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin:: Methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models
M Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1β-methylcarbapenems with potent activities against multiresistant gram-positive bacteria
Y Ueda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms
CE Jamieson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals
P Giakkoupi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
AmpC β-lactamases:: what do we need to know for the future?
ND Hanson
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety
I Kawamoto et al.
JOURNAL OF ANTIBIOTICS (2003)
In vitro and in vivo activities of AM-112, a novel oxapenem
CE Jamieson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
IMP-12, a new plasmid-encoded metallo-β-lactamase from a Pseudomonas putida clinical isolate
JD Docquier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Aminoglycoside efflux in Pseudomonas aeruginosa:: Involvement of novel outer membrane proteins
JTH Jo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci
T Fujimura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases
F Malouin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Ertapenem - A review of its use in the management of bacterial infections
MP Curran et al.
DRUGS (2003)
Chromosome-encoded ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci
RN Jones et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa synthesis and structure-activity relationships
H Yoshizawa et al.
JOURNAL OF ANTIBIOTICS (2002)
Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America:: report from the SENTRY antimicrobial surveillance programme
MA Toleman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland
A Baraniak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
β-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types
C Humeniuk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
The structural bases of antibiotic resistance in the clinically derived mutant β-lactamases TEM-30, TEM-32, and TEM-34
XJ Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Novel class 1 integron (InS21) carrying blaCTX-M-2 in Salmonella enterica serovar infantis
J Di Conza et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci
JC Fung-Tomc et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Activities of faropenem, an oral β-lactam, against recent US isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
IA Critchley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
A new integron carrying VIM-2 metallo-beta-lactamase gene cassette in a Serratia marcescens isolate
JH Yum et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents
GA Pankuch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds
DB Hoellman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
First isolation of a carbapenem-hydrolyzing beta-lactamase in Pseudomonas aeruginosa in Spain
G Prats et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Characterization of a chromosomally encoded extended-spectrum class A β-lactamase from Kluyvera cryocrescens
JW Decousser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem
L Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Metallo-β-lactamases in clinical Pseudomonas isolates in taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme
JJ Yan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains
RN Jones
JOURNAL OF CHEMOTHERAPY (2001)
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia
DM Livermore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 β-lactamase and lacking an outer membrane protein
TH Koh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers
PC Fuchs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria
S Chamberland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci
P Hebeisen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Inhibition of the SHV-1 β-lactamase by sulfones:: Crystallographic observation of two reaction intermediates with tazobactam
AP Kuzin et al.
BIOCHEMISTRY (2001)
In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections
S Miyazaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
SME-type carbapenem-hydrolyzing class A β-lactamases from geographically diverse Serratia marcescens strains
AM Queenan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Discovery of RWJ-54428 (MC-02,479), a new cephalosporin active against resistant Gram-positive bacteria
SJ Hecker et al.
JOURNAL OF ANTIBIOTICS (2000)
Amino acid substitutions in a variant of IMP-1 metallo-β-lactamase
S Iyobe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1 beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa
R Nagano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
